Population-based analysis of CHEK2 pathogenic variants and their functional role in breast cancer development
Regulatory Mechanisms in Biosystems · 2026-01-29 · 17 (1) · e26016
DOI: 10.15421/0226016 ↗At a glance
Journal article in Regulatory Mechanisms in Biosystems, published online on 2026-01-29. Written by N. Khudoyberdieva and 9 co-authors. 51 references.
Abstract (original language)
CHEK2 is an essential tumor suppressor gene involved in DNA damage response and cell cycle regulation, and its germline variants are known to increase breast cancer suscept i bility. However, evidence regarding the clinical and molecular relevance of CHEK2 variants in Central Asian populations remains limited. This study aimed to assess the distribution and clinicopathological significance of the CHEK2 IVS2+1G>A and Ile157Thr polymorphisms in Uzbek women with breast cancer, with emphasis on molecular subtypes, immunohistochemical markers, and menopausal status. The study included 200 breast ca n cer patients and 100 conditionally healthy controls. CHEK2 polymorphisms were identified using PCR-based genotyping. Associations with clinicopathological features and immunohistochemical markers (ER, PR, HER2/ neu , Ki -67) were evaluated using odds ratios, relative risk estimates, χ² test, and Fisher’s exact test. The IVS2+1G>A variant was significantly associated with hormone receptor–positive tumors, predominantly luminal subtypes, and was more frequently observed in postmenopausal patients. In contrast, the Ile157Thr polymorphism showed a wider age distribution and was linked to a heterogeneous molecular profile, including highly proliferative and triple-negative breast cancer subtypes. Distinct patterns of hormone receptor expression and Ki-67 levels suggested variant-specific biological behavior. These findings demonstrate that CHEK2 polymorphisms differentially influence breast cancer risk and phenotype in a menopause-dependent manner. The results highlight the importance of population-specific genetic profiling and support the potential utility of CHEK2 variants in personalized risk stratification for breast cancer in Uzbek wo m en.
Cite
APA
Khudoyberdieva, N., Amanturdiev, I., Boqieva, G., Arabova, N., Shakarboeva, S., Ziyamukhamedova, S., Umorov, M., Avezov, N., Akhmedov, K., & Burieva, K. (2026). Population-based analysis of CHEK2 pathogenic variants and their functional role in breast cancer development. Regulatory Mechanisms in Biosystems, 17(1), e26016. https://doi.org/10.15421/0226016
Vancouver
Khudoyberdieva N, Amanturdiev I, Boqieva G, Arabova N, Shakarboeva S, Ziyamukhamedova S, et al. Population-based analysis of CHEK2 pathogenic variants and their functional role in breast cancer development. Regulatory Mechanisms in Biosystems. 2026;17(1):e26016. doi:10.15421/0226016
BibTeX
@article{Khudoyberdieva2026,
author = {Khudoyberdieva, N. and Amanturdiev, I. and Boqieva, G. and Arabova, N. and Shakarboeva, S. and Ziyamukhamedova, S. and Umorov, M. and Avezov, N. and Akhmedov, K. and Burieva, K.},
title = {Population-based analysis of CHEK2 pathogenic variants and their functional role in breast cancer development},
journal = {Regulatory Mechanisms in Biosystems},
year = {2026},
volume = {17},
number = {1},
pages = {e26016},
doi = {10.15421/0226016}
}
EUVIMED